Interferon-α-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax

Oncogene

Volumn 22, Issue 29, 2003, Pages 4543-4556

  Panaretakis, Theocharis ^a   Pokrovskaja, Katja ^a   Shoshan, Maria C ^a   Grandér, Dan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Bak; Bax; Bcl 2; IFN

Indexed keywords

ALPHA INTERFERON; CALPAIN; CASPASE; CASPASE 10; CASPASE 3; CASPASE INHIBITOR; CYTOCHROME C; INTERLEUKIN 1BETA CONVERTING ENZYME; P38 STRESS ACTIVATED PROTEIN KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE ACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; STAINING; STRESS; TUMOR CELL LINE;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BURKITT LYMPHOMA; CALPAIN; CARRIER PROTEINS; CASPASES; CYSTEINE PROTEINASE INHIBITORS; CYTOCHROME C GROUP; ENZYME INHIBITORS; HUMANS; INTERFERON-ALPHA; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; MULTIPLE MYELOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0043170846     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206503     Document Type: Article

References (37)

1. Bellosillo B, Villamor N, Lopez-Guillermo A, Marce S, Bosch F, Campo E, Montserrat E and Colomer D. (2002). Blood, 100, 1810-1816.
2. Bradbury DA, Zhu YM and Russell NH. (1997). Leukemia Lymphoma, 24, 221-228.
3. Cai J and Jones DP. (1999). J. Bioenerg. Biomembr., 31, 327-334.
4. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R. (1999). Immunity, 10, 105-115.
5. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T and Korsmeyer SJ. (2001). Mol. Cell, 8, 705-711.
6. Consoli U, Santonocito A, Stagno F, Fiumara P, Privitera A, Parisi G, Giustolisi GM, Pavone B, Palumbo GA, Di Raimondo F, Milone G, Guglielmo P and Giustolisi R. (2002). Br. J. Haematol., 116, 774-780.
7. Dai C and Krantz SB. (1999). Blood, 93, 3309-3316.
8. Desagher S and Martinou JC. (2000). Trends Cell. Biol., 10, 369-377.
9. Grander D. (2000). Acta Oncol., 39, 801-805.
10. Griffiths GJ, Dubrez L, Morgan CP, Jones NA, Whitehouse J, Corfe BM, Dive C and Hickman JA. (1999). J. Cell. Biol., 144, 903-914.
11. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T and Alnemri ES. (2002). J. Biol. Chem., 277, 13430-13437.
12. Ichijo H. (1999). Oncogene, 18, 6087-6093.
13. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ and Schlesinger PH. (2000). Cell Death Differ., 7, 1166-1173.
14. Krammer PH. (2000). Nature, 407, 789-795.
15. Lassus P, Opitz-Araya X and Lazebnik Y. (2002). Science, 297, 1352-1354.
16. Loeffler M and Kroemer G. (2000). Exp. Cell Res., 256, 19-26.
17. Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K and Debatin KM. (1997). Blood, 90, 3118-3129.
18. Ludwig H and Fritz E. (2000). Acta Oncol., 39, 815-821.
19. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. (1998). Cell, 94, 481-490.
20. Lutz RJ. (2000). Biochem. Soc. Trans., 28, 51-56.
21. Mandic A, Viktorsson K, Strandberg L, Heiden T, Hansson J, Linder S and Shoshan MC. (2002). Mol. Cell. Biol., 22, 3003-3013.
22. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM and Strasser A. (2002). Nature, 419, 634-637.
23. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, Prevost MC, Xie Z, Matsuyama S, Reed JC and Kroemer G. (1998). Science, 281, 2027-2031.
24. Nechushtan A, Smith CL, Hsu YT and Youle RJ. (1999). EMBO J., 18, 2330-2341.
25. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW and Adams JM. (1999). Proc. Natl. Acad. Sci. USA, 96, 14943-14948.
26. Panaretakis T, Pokrovskaja K, Shoshan MC and Grander D. (2002). J. Biol. Chem., 277(46), 44317-26.
27. Puthalakath H and Strasser A. (2002). Cell Death Differ., 9, 505-512.
28. Puthier D, Thabard W, Rapp M, Etrillard M, Harousseau J, Bataille R and Amiot M. (2001). Br. J. Haematol., 112, 358-363.
29. Raza A. (2000). Leukemia Res., 24, 63-72.
30. Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S and Grander D. (1997). Cell Growth Differ., 8, 343-352.
31. Sangfelt O, Osterborg A, Grander D, Anderbring E, Ost A, Mellstedt H and Einhorn S. (1995). Int. J. Cancer, 63, 190-192.
32. Smalley RV, Weller E, Hawkins MJ, Oken MM, O'Connell MJ, Haase-Statz S and Borden BC. (2001). Leukemia, 15, 1118-1122.
33. Strander H and Einhorn S. (1996). Biotherapy, 8, 213-218.
34. Thyrell L, Erickson S, Zhivotovsky B, Pokrovskaja K, Sangfelt O, Castro J, Einhorn S and Grander D. (2002). Oncogene, 21, 1251-1262.
35. Wang GQ, Gastman BR, Wieckowski E, Goldstein LA, Gambotto A, Kim TH, Fang B, Rabinovitz A, Yin XM and Rabinowich H. (2001). J. Biol. Chem., 276, 34307-34317.
36. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB and Korsmeyer SJ. (2000). Genes Dev., 14, 2060-2071.
37. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ. (2001). Science, 292, 727-730.